17 research outputs found
Normal and unusual days for dietary intake during the 12Â months after a breast cancer diagnosis in women
Purpose There are several reasons to report days as being unusual with regard to dietary intake, including special occasions
and celebrations. For breast cancer patients during the 12 month post-surgery period, unusual days may also include days
that are afected by being a cancer patient. The aim of this study was to study dietary intake on ânormalâ and âunusualâ days,
and to study what is reported in âfree text feldsâ of a food diary.
Methods Women (n=456), mean age 55.5 years newly diagnosed with invasive breast cancer (stage I/II) were included in
this clinical study. âNormalâ and âunusualâ days in general, over time and during the week and weekends were studied using
repeated administration of a 7-day pre-coded food diary.
Results The breast cancer patients reported 26% of all days as unusual. The intake of energy, most nutrients, especially
alcohol and sugar, red and processed meat, and sweets, cakes, and snacks was 5â126% higher, whereas intake of fber, fruit
and berries, vegetables, and dairy products was 7â17% lower on unusual than on normal days (P<0.001). The same pattern
was seen for normal/unusual days during the weekdays, weekends and over time. Finally, 99% of the breast cancer patients
used the free text felds to report additional intake with a mean energy of 1.1 MJ/day.
Conclusion For breast cancer patients during the 12-month post-surgery period, unusual days are important drivers of total
intake, especially for alcohol. The free text felds in the pre-coded food diary contributed substantially to the total intake
Screening-detected desmoid tumor of the breast: Findings at conventional imaging and digital breast tomosynthesis.
Desmoid tumor of the breast is a rare benign entity that usually is mistaken for carcinoma clinically and radiologically. We report two cases of desmoid tumor of the breast detected by mammography screening using digital breast tomosynthesis (DBT). The larger tumor was detected at both full-field digital mammography (FFDM) and DBT. The smaller desmoid tumor, however, was identified only at tomosynthesis. Mammographic and ultrasonographic findings at diagnostic work-up were consistent with carcinoma of the breast. Preoperative needle biopsies could not conclusively diagnose the lesions. Both patients underwent excisional biopsy and histopathology revealed fibromatosis of the desmoid type
Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based study
Background: Mammography screen-detected breast cancers have a better prognosis than predicted from established prognostic markers. A search for additional features that are characteristic for these tumours and their prognosis is needed to reduce overtreatment, a recognized challenge in breast cancer patient management today. Here, we have investigated the occurrence and importance of tumour elastosis. Methods: We performed a population based retrospective study of breast cancers detected in the Norwegian Breast Cancer Screening Programme in Vestfold County during 2004â2009. In total, 197 invasive screen-detected cancers and 75 interval cancers in patients aged 50â69 years were compared with regard to standard clinico-pathological parameters and tumour shape, as well as ER, PR, HER2 and Ki67 expression. In particular, the presence of elastotic material in tumours was graded on a 4-tiered scale (score 0â3). Results: Screen-detected cancers had a significantly higher content of stromal elastosis than interval cancers (p < 0.001). High content of elastosis (score 3) correlated strongly with stellate tumour shape, low histological grade, and ER+/HER2- status. Further, high elastosis score was significantly associated with lower Ki67 expression. In survival analyses, cases with high elastosis demonstrated increased recurrence free (p = 0.03) and disease-specific survival (p = 0.11) compared to cases with low elastosis. Conclusion: There is a strong correlation between the presence of tumour elastosis, stellate tumour shape and mammography detection of breast cancers. To our knowledge, this is the first time elastosis has been studied in relation to breast cancer detection method. Presence of elastosis is associated with low tumour cell proliferation (Ki67) and a good prognosis
Genetic characterization of myoid hamartoma of the breast
Background/Aim: Myoid hamartoma of the breast is a very rare benign lesion of which only a few cases have been reported. The pathogenesis is unknown and nothing is known about its genetic constitution. We report here the genetic characterization of a myoid hamartoma of the breast. Materials and Methods: Cytogenetic, fluorescence in situ hybridization (FISH), RNA sequencing, reverse transcription polymerase chain reaction (RT-PCR), and Sanger sequencing analyses were performed on a myoid hamartoma of the breast. Results: G-Banding analysis of short-term cultured tumor cells yielded the karyotype 46,XX,t(5;12)(p13;q14)[6]/46,XX[4]. FISH showed rearrangement of the high mobility group AT-hook 2 (HMGA2) gene. RNA sequencing detected fusion of HMGA2 (12q14) with a sequence from 5p13. RT-PCR together with Sanger sequencing verified the HMGA2-fusion transcript. Conclusion: Myoid hamartoma of the breast may be pathogenetically related to benign connective tissue tumors with HMGA2 rearrangements, such as pulmonary hamartomas, lipomas, myolipomas, and leiomyomas
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
Background:
High-Density Lipoprotein (HDL)-cholesterol, has been associated with breast cancer development, but the association is under debate, and whether lipoprotein subfractions is associated with breast tumor characteristics remains unclear.
Methods:
Among 56 women with newly diagnosed invasive breast cancer stage I/II, aged 35â75 years, pre-surgery overnight fasting serum concentrations of lipids were assessed, and body mass index (BMI) was measured. All breast tumors were immunohistochemically examined in the surgical specimen. Serum metabolomics of lipoprotein subfractions and their contents of cholesterol, free cholesterol, phospholipids, apolipoprotein-A1 and apolipoprotein-A2, were assessed using nuclear magnetic resonance. Principal component analysis, partial least square analysis, and uni- and multivariable linear regression models were used to study whether lipoprotein subfractions were associated with breast cancer tumor characteristics.
Results:
The breast cancer patients had following means: age at diagnosis: 55.1 years; BMI: 25.1 kg/m2; total-Cholesterol: 5.74 mmol/L; HDL-Cholesterol: 1.78 mmol/L; Low-Density Lipoprotein (LDL)-Cholesterol: 3.45 mmol/L; triglycerides: 1.18 mmol/L. The mean tumor size was 16.4 mm, and the mean Ki67 hotspot index was 26.5 %. Most (93 %) of the patients had estrogen receptor (ER) positive tumors (âĽ1 % ER+), and 82 % had progesterone receptor (PgR) positive tumors (âĽ10 % PgR+). Several HDL subfraction contents were strongly associated with PgR expression: Apolipoprotein-A1 (β 0.46, CI 0.22â0.69, pâ<â0.001), HDL cholesterol (β 0.95, CI 0.51â1.39, pâ<â0.001), HDL free cholesterol (β 2.88, CI 1.28â4.48, pâ=â0.001), HDL phospholipids (β 0.70, CI 0.36â1.04, pâ<â0.001). Similar results were observed for the subfractions of HDL1-3. We observed inverse associations between HDL phospholipids and Ki67 (β -0.25, pâ=â0.008), and in particular between HDL1âs contents of cholesterol, phospholipids, apolipoprotein-A1, apolipoprotein-A2 and Ki67. No association was observed between lipoproteins and ER expression.
Conclusion:
Our findings hypothesize associations between different lipoprotein subfractions, and PgR expression, and Ki 67 % in breast tumors. These findings may have clinical implications, but require confirmation in larger studies
Lipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer
Background: High-Density Lipoprotein (HDL)-cholesterol, has been associated with breast cancer development, but
the association is under debate, and whether lipoprotein subfractions is associated with breast tumor characteristics
remains unclear.
Methods: Among 56 women with newly diagnosed invasive breast cancer stage I/II, aged 35â75 years, pre-surgery
overnight fasting serum concentrations of lipids were assessed, and body mass index (BMI) was measured. All breast
tumors were immunohistochemically examined in the surgical specimen. Serum metabolomics of lipoprotein
subfractions and their contents of cholesterol, free cholesterol, phospholipids, apolipoprotein-A1 and apolipoprotein-A2,
were assessed using nuclear magnetic resonance. Principal component analysis, partial least square analysis,
and uni- and multivariable linear regression models were used to study whether lipoprotein subfractions were associated
with breast cancer tumor characteristics.
Results: The breast cancer patients had following means: age at diagnosis: 55.1 years; BMI: 25.1 kg/m2
; total-Cholesterol:
5.74 mmol/L; HDL-Cholesterol: 1.78 mmol/L; Low-Density Lipoprotein (LDL)-Cholesterol: 3.45 mmol/L; triglycerides:
1.18 mmol/L. The mean tumor size was 16.4 mm, and the mean Ki67 hotspot index was 26.5 %. Most (93 %) of the
patients had estrogen receptor (ER) positive tumors (âĽ1 % ER+), and 82 % had progesterone receptor (PgR)
positive tumors (âĽ10 % PgR+). Several HDL subfraction contents were strongly associated with PgR expression:
Apolipoprotein-A1 (β 0.46, CI 0.22â0.69, p < 0.001), HDL cholesterol (β 0.95, CI 0.51â1.39, p < 0.001), HDL free cholesterol
(β 2.88, CI 1.28â4.48, p = 0.001), HDL phospholipids (β 0.70, CI 0.36â1.04, p < 0.001). Similar results were observed for the
subfractions of HDL1-3. We observed inverse associations between HDL phospholipids and Ki67 (β -0.25, p = 0.008), and
in particular between HDL1âs contents of cholesterol, phospholipids, apolipoprotein-A1, apolipoprotein-A2 and Ki67. No
association was observed between lipoproteins and ER expression.
Conclusion: Our findings hypothesize associations between different lipoprotein subfractions, and PgR expression, and Ki 67 % in breast tumors. These findings may have clinical implications, but require confirmation in larger studie
Dietary changes in early-stage breast cancer patients from pre-surgery and over the 12 months post-surgery
The time after a breast cancer diagnosis is a potential period for making positive dietary changes, but previous results are conflicting. The main aim of the present study was to study breast cancer patientsâ dietary changes during the 12 months post-surgery and from 12 months pre-surgery to 12 months post-surgery with repeated administration of a 7-d pre-coded food diary and an FFQ, respectively. Women (n 506), mean age 55¡3 years diagnosed with invasive breast cancer (stages I and II), were included. The dietary intake was quite stable over time, but the intake was lower for energy (0¡3 and 0¡4 MJ/d), alcohol (1¡9 and 1¡5 g/d) and vegetables (17 and 22 g/d) at 6 months than 3 weeks post-surgery (food diary) and at 12 months post-surgery than pre-surgery (FFQ), respectively. Furthermore, energy percentage (E%) from carbohydrates increased between 0¡8 and 1¡2 E% and E% from fat decreased between 0¡6 and 0¡8 E% over time, measured by both dietary assessment methods. We observed a higher intake of dairy products (11 g/d) at 6 months post-surgery (food diary), and a lower intake of dairy products (34 g/d) and red and processed meat (7¡2 g/d) at 12 months post-surgery (FFQ). Moreover, 24 % of the patients claimed they made dietary changes, but mostly they did not change their diet differently compared with those patients who claimed no changes. In conclusion, breast cancer patients reported only minor dietary changes from 12 months pre-surgery and during the 12 months post-surgery
Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Digital Mammography: Evaluation in a Population-based Screening Program
Purpose: To compare the performance of digital breast tomosynthesis (DBT) and two-dimensional synthetic mammography (SM) with that of digital mammography (DM) in a population-based mammographic screening program.
Materials and Methods: In this prospective cohort study, data from 37 185 women screened with DBT and SM and from 61 742 women screened with DM as part of a population-based screening program in 2014 and 2015 were included. Early performance measures, including recall rate due to abnormal mammographic findings, rate of screen-detected breast cancer, positive predictive value of recall, positive predictive value of needle biopsy, histopathologic type, tumor size, tumor grade, lymph node involvement, hormonal status, Ki-67 level, and human epidermal growth factor receptor 2 status were compared in women who underwent DBT and SM screening and in those who underwent DM screening by using x2 tests, two-sample unpaired t tests, and tests of proportions.
Results: Recall rates were 3.4% for DBT and SM screening and 3.3% for DM screening (P = .563). DBT and SM screening showed a significantly higher rate of screen-detected cancer compared with DM screening (9.4 vs 6.1 cancers per 1000 patients screened, respectively; P , .001). The rate of detection of tumors 10 mm or smaller was 3.2 per 1000 patients screened with DBT and SM and 1.8 per 1000 patients screened with DM (P , .001), and the rate of grade 1 tumors was 3.3 per 1000 patients screened with DBT and SM versus 1.4 per 1000 patients screened with DM (P , .001). On the basis of immunohistochemical analyses, rates of lymph node involvement and tumor subtypes did not differ between women who underwent DBT and SM screening and those who underwent DM screening.
Conclusion: DBT and SM screening increased the detection rate of histologically favorable tumors compared with that attained with DM screening
Inflammation of mammary adipose tissue occurs in overweight and obese patients exhibiting early-stage breast cancer
Growing evidence indicates that adiposity is associated with breast cancer risk and negatively affects breast cancer recurrence and survival, a paracrine role of mammary adipose tissue being very likely in this process. In contrast to other adipose depots, occurrence of a sub-inflammatory state of mammary adipose tissue defined by dying adipocytes surrounded by macrophages forming crown-like structures in overweight and obese subjects, remains only partially described. In a general population of breast cancer patients (107 patients) mostly undergoing breast-conserving surgery, we found a positive association between patientâs body composition, breast adipocytes size, and presence of crown-like structures in mammary adipose tissue close to the tumor. Overweight (BMI: 25.0â29.9âkg/m2) and obese (BMIââĽâ30.0âkg/m2) patients have 3.2 and 6.9 times higher odds ratio of crown-like structures respectively, compared with normal weight patients. The relatively small increase in adipocyte size in crown-like structures positive vs. negative patients suggests that mammary adipose tissue inflammation might occur early during hypertrophy. Our results further highlight that body mass index is an adequate predictor of the presence of crown-like structures in mammary adipose tissue among postmenopausal women, whereas in premenopausal women truncal fat percentage might be more predictive, suggesting that mammary adipose tissue inflammation is more likely to occur in patients exhibiting visceral obesity. Finally, the presence of crown-like structures was positively associated with systemic markers such as the Triglyceride/High-density lipoprotein-cholesterol ratio serum C-reactive protein and glucose/(HbA1c) glycated Haemoglobin. These compelling results demonstrate that excess adiposity, even in overweight patients, is associated with mammary adipose tissue inflammation, an event that could contribute to breast cancer development and progression